Clinicopathological and prognostic significance of platelet to lymphocyte ratio in patients with gastric cancer

Xiaobin Gu; Xian-Shu Gao; Ming Cui; Mu Xie; Chuan Peng; Yun Bai; Wei Guo; Linjun Han; Xiaodong Gu; Wei Xiong

doi:10.18632/oncotarget.10490

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Clinicopathological and prognostic significance of platelet to lymphocyte ratio in patients with gastric cancer

Xiaobin Gu, Xian-Shu Gao _, Ming Cui, Mu Xie, Chuan Peng, Yun Bai, Wei Guo, Linjun Han, Xiaodong Gu and Wei Xiong

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2016; 7:49878-49887. https://doi.org/10.18632/oncotarget.10490

Metrics: PDF 2032 views | HTML 3809 views | ?

Abstract

Xiaobin Gu1, Xian-Shu Gao1, Ming Cui1, Mu Xie1, Chuan Peng1, Yun Bai1, Wei Guo2, Linjun Han2, Xiaodong Gu3, Wei Xiong4

1Department of Radiation Oncology, Peking University First Hospital, Peking University, Beijing, China

2Graduate School of Medicine, Hebei North University, Zhangjiakou, Hebei, China

3Department of Breast Cancer Radiotherapy, Tumor Hospital of Shanxi Provence, Taiyuan, China

4Department of Oncology, Tangshan People’s Hospital, Hebei, China

Correspondence to:

Xian-Shu Gao, email: [email protected]

Keywords: PLR, gastric cancer, biomarker, prognosis, meta-analysis

Received: March 29, 2016 Accepted: June 30, 2016 Published: July 08, 2016

ABSTRACT

The present study was aim to investigate the prognostic role of platelet to lymphocyte ratio (PLR) for patients with gastric cancer (GC) using meta-analysis. A total of 13 studies (14 cohorts) with 6,280 subjects were included. By pooling hazard ratios (HRs) and 95% confidence intervals (CIs) and odds ratios (ORs) and 95% CIs from each study, we found that elevated PLR was significantly associated with poorer overall survival (OS) (HR: 1.3, 95% CI: 1.1–1.52, p = 0.001; Ι² = 68.5%, P_h < 0.001) but not with poor disease-free survival (DFS) (HR: 1.6, 95% CI: 0.88–2.9, p = 0.122; I² = 87.8%, P_h < 0.001). Subgroup analysis showed that a high PLR significantly predicted poor OS in Caucasian populations, patients receiving chemotherapy and patients at advanced stage. In addition, the cut-off value of PLR > 160 showed adequately prognostic value. Furthermore, elevated PLR was associated with lymph node metastasis and CEA levels in GC. Our meta-analysis showed that elevated PLR could be a significant prognostic biomarker for poor OS in patients with GC.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 10490

Publication Alerts

Research Papers:

Clinicopathological and prognostic significance of platelet to lymphocyte ratio in patients with gastric cancer

Abstract